Cell Metab 36(10): 21732189
Food and Drug Administration has approved only one pharmacologic treatment (i.e., resmetirom) specifically for MASH or its precursor, NASH (nonalcoholic steatohepatitis), while the European Medicines Agency and Chinas National Medical Products Administration have approved none
Start With an Assessment Complete a health assessment, and a licensed clinician will determine if GLP-1 treatment is right for your weight loss goals
Benefits include improved exercise performance and potential weight loss support
Phytomedicine, 19 (10), 861-867
A screening, like Prenuvos Body Composition Analysis can provide comprehensive health information such as detailed information about your muscle mass and how much visceral fat you may have